Screener
CVRx, Inc. CVRX Q2 2026 earnings
Reported August 6, 2026 · After market close
Revenue$15.7MBeat by $155.7K
EPS-$0.53Miss by $0.01
Revenue estimate$15.5M
EPS estimate-$0.52
“We are pleased with the strong revenue growth and margin performance in the second quarter along with the reimbursement progress we made, including the new Medicare Advantage coverage policy from Humana. However, we are not satisfied with our updated outlook for the balance of the year, driven by fewer sales territories than anticipated, lower sales force productivity and a prolonged challenge with one of our largest payers. We are taking direct action to address these headwinds, and our confidence in the long-term fundamentals of this business remains high, supported by strong growth observed in our most stable regions and encouraging early progress on the BENEFIT-HF trial and our broader clinical and reimbursement strategies.”
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$13.9M
EPS estimate-$0.49
Versus estimates
Revenue
Diluted EPS
FAQ
- When did CVRx, Inc. report Q2 2026 earnings?
- CVRx, Inc. (CVRX) reported Q2 2026 earnings on August 6, 2026 after market close.
- What were CVRx, Inc.'s Q2 2026 revenue and EPS?
- CVRx, Inc. reported revenue of $15.7M and eps of $-0.53 for Q2 2026.
- Did CVRx, Inc. beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $15.5M by $155.7K. EPS missed the consensus estimate of $-0.52 by $0.01.
- How did CVRx, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 15.6% from $13.6M a year earlier and eps grew 7.0% from $-0.57.
- Where can I find CVRx, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-092005) and the 10-Q periodic report (0001628280-26-054336) directly on SEC EDGAR. The filing index links above go to sec.gov.
